ASPEN AEROGELS INC ASPN

Rank #1676 · NYSE · $0.4B market cap

Audited by KPMG LLP, no going-concern flag in the latest filing.

Score

44.5

P/E

-9.1

P/B

0.94

ROE

-10.2%

Op. Margin

-20.6%

Debt Ratio

63%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Average

P/E -9.1x, P/B 0.94x. Ranks in the top 50% of the universe.

Profitability ★☆☆☆☆

Weak

ROE -10.2%. Ranks in the top 79% of the universe.

Safety ★★★★☆

Good

Debt ratio 63%. Ranks in the top 27% of the universe.

Growth ★★★★☆

Excellent

Revenue growth of 32.4% year over year. Ranks in the top 11% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2014	–	$-0.0B	$-0.1B	$-0.1B	–	-134
2015	–	$-0.0B	$-0.0B	$-0.1B	–	-18
2016	–	$-0.0B	$-0.1B	$-0.1B	–	-28
2017	–	$-0.0B	$-0.0B	$0.1B	–	15
2018	$0.1B	$-0.0B	$-0.0B	$0.1B	-9.5	19
2019	$0.1B	$-0.0B	$-0.0B	$0.1B	-17.1	25
2020	$0.1B	$-0.0B	$-0.0B	$0.1B	-32.5	44
2021	$0.1B	$-0.0B	$-0.0B	$0.1B	-10.2	42
2022	$0.1B	$-0.0B	$-0.0B	$0.1B	-21.5	92
2023	$0.1B	$-0.0B	$-0.0B	$0.1B	-33.4	289
2024	$0.2B	$-0.1B	$-0.1B	$0.1B	-43.9	167
2025	$0.2B	$-0.0B	$-0.0B	$0.4B	-20.6	63